Controversial points in organ donor management.

Area of Science:

• Critical Care Medicine
• Transplantation Immunology
• Endocrinology

Background:

• Brain death triggers significant organ alterations, impacting transplant viability.
• Optimal management strategies for organ donors remain controversial.
• Key aspects include maintaining perfusion pressure, hormone balance, and controlling inflammation.

Purpose of the Study:

• To review and recommend best practices for organ donor management.
• To evaluate the efficacy and justification of specific interventions like hormone therapy and anti-inflammatory agents.

Main Methods:

• Review of current literature on organ donor management protocols.
• Analysis of the physiological effects of brain death on organ systems.
• Evaluation of pharmacological interventions for donor optimization.

Main Results:

• Catecholamine dosing is highly individualized based on donor hemodynamics.
• Desmopressin is recommended for managing diabetes insipipidus.
• Methylprednisolone is recommended for its immunomodulatory effects, low cost, and safety profile.
• Triiodothyronine is not currently recommended due to insufficient evidence, cost, and potential side effects.

Conclusions:

• Effective organ donor management requires a multi-faceted approach addressing perfusion, hormonal status, and inflammation.
• Methylprednisolone offers significant benefits in mitigating inflammatory responses and improving organ viability.
• Further research is needed, but current evidence supports methylprednisolone over triiodothyronine in organ donor management.